Ledger.Open graph →
SEC Form D · filed October 5, 2015

Orionis Biosciences LLC

Offering
$5.3M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Griet R. Vanpoucke, Ph.D · Boston, MADirectorSteven R. Gullans, Ph.D · Boston, MADirectorNikolai Kley, Ph.D · Boston, MAExec · DirectorGriet R. Vanpoucke, Ph.D · Boston, MADirectorSteven R. Gullans, Ph.D · Boston, MADirectorNikolai Kley, Ph.D · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗